Juan P. Cueva, Ph.D.

Affiliations: 
Medicinal Chemistry and Molecular Pharmacology Purdue University, West Lafayette, IN, United States 
Area:
Dopamine and Serotonin Agonists
Google:
"Juan Cueva"
Mean distance: 18.16 (cluster 11)
 

Parents

Sign in to add mentor
David E. Nichols grad student 2008 Purdue
 (Inquiry into the structural and conformational requirements of beta-phenyldopamine-type ligands for selective dopamine D1 receptor activation.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Juncosa JI, Hansen M, Bonner LA, et al. (2013) Extensive rigid analogue design maps the binding conformation of potent N-benzylphenethylamine 5-HT2A serotonin receptor agonist ligands. Acs Chemical Neuroscience. 4: 96-109
Cueva JP, Chemel BR, Juncosa JI, et al. (2012) Analogues of doxanthrine reveal differences between the dopamine D1 receptor binding properties of chromanoisoquinolines and hexahydrobenzo[a]phenanthridines. European Journal of Medicinal Chemistry. 48: 97-107
Cueva JP, Gallardo-Godoy A, Juncosa JI, et al. (2011) Probing the steric space at the floor of the D1 dopamine receptor orthosteric binding domain: 7α-, 7β-, 8α-, and 8β-methyl substituted dihydrexidine analogues. Journal of Medicinal Chemistry. 54: 5508-21
Clark LH, Cueva JP, McCorvy JD, et al. (2011) C-Ring expanded analogs of doxanthrine: Conformation plays a critical role Arkivoc. 2010: 125-138
Przybyla JA, Cueva JP, Chemel BR, et al. (2009) Comparison of the enantiomers of (+/-)-doxanthrine, a high efficacy full dopamine D(1) receptor agonist, and a reversal of enantioselectivity at D(1) versus alpha(2C) adrenergic receptors. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 19: 138-46
Cueva JP, Nichols DE. (2009) A novel and efficient synthesis of dihydrexidine Synthesis. 715-720
Cueva JP, Giorgioni G, Grubbs RA, et al. (2006) trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D1 receptor full agonist. Journal of Medicinal Chemistry. 49: 6848-57
See more...